文献速递认知障碍与痴呆

突触、淀粉样蛋白与tau蛋白的三方关系:体内与尸检研究

Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study.
PubMed 文献 · Neurology · 2021-07-19

本研究在社区居住的临床正常老年人中检验A/T/N级联关系是否依赖突触完整性,采用两个独立横断面队列:体内脑脊液突触蛋白与Aβ42/40、ptau181及MRI灰质体积,以及尸检脑组织突触前蛋白与斑块和缠结计数。结果显示脑脊液突触蛋白调节Aβ与tau及tau与灰质体积的关系,尸检分析再现了脑脊液模型,提示突触标志物可能帮助识别AD蛋白病变的风险或韧性。

要点

  • 脑脊液突触蛋白调节Aβ42/40与ptau181及ptau181与灰质体积的关系
  • 突触蛋白更正常者中Aβ-ptau和ptau-脑体积关系消失或反转
  • 尸检脑组织complexin-I、VAMP和SNARE调节斑块与缠结的不良关系

核心结论

  • Aβ与tau的致病关系可能依赖突触状态,突触标志物或有助于识别AD蛋白病变的风险或韧性。

研究设计与样本

  • 两个独立观察性横断面队列:体内为加州大学旧金山分校记忆与老化中心的社区居住临床正常老年人,完成腰椎穿刺和MRI(排除临床痴呆评定量表>0);尸检为Rush记忆与老化项目死者(排除无法签署知情同意)。

主要发现

  • 体内队列68名老年人(年龄71岁,43%女性),每个脑脊液突触蛋白调节Aβ42/40与ptau181的关系(-0.23<β<-0.12,p<0.05)及ptau181与灰质体积的关系(-0.49<β<-0.32,p<0.05)。
  • 尸检队列633名死者(年龄90岁,68%女性,34%临床正常),脑组织complexin-I、VAMP和SNARE更正常者调节神经炎斑块与NFT计数的不良关系(-0.10<β<-0.08,p<0.05)。

临床怎么用

  • 突触标志物可能辅助识别AD蛋白病变的风险或韧性,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that fundamental relationships along the amyloid, tau, and neurodegeneration (A/T/N) cascade depend on synaptic integrity in older adults in vivo and postmortem. METHODS: The 2 independent observational, cross-sectional cohorts included (1) in vivo community-dwelling, clinically normal adults from the University of California, San Francisco Memory and Aging Center who completed lumbar puncture and MRI (exclusion criteria, Clinical Dementia Rating score >0) and (2) postmortem decedents from the Rush Memory and Aging Project (exclusion criteria, inability to sign informed consent). In vivo measures included CSF synaptic proteins (synaptotagmin-1, synaptosome associated protein-25, neurogranin, and growth associated protein-43), β-amyloid (Aβ42/40), tau phosphorylated at amino acid 181 (ptau181), and MRI gray matter volume (GMV). Postmortem measures captured brain tissue levels of presynaptic proteins (complexin-I, complexin-II, vesicle associated membrane protein (VAMP), and SNARE complex) and neuritic plaque and neurofibrillary tangle (NFT) counts. Regression models tested statistical moderation of synaptic protein levels along the A/T/N cascade (synaptic proteins × amyloid on tau, and synaptic proteins × tau on GMV). RESULTS: Sixty-eight in vivo older adults (age 71 years, 43% female) and 633 decedents (age 90 years, 68% female, 34% clinically normal) were included. Each in vivo CSF synaptic protein moderated the relationship between Aβ42/40 and ptau181 (-0.23 < β < -0.12, p < 0.05) and the relationship between ptau181 and GMV (-0.49 <β < -0.32, p < 0.05). Individuals with more abnormal CSF synaptic protein demonstrated expected relationships between Aβ-ptau181 and ptau181-brain volume, effects that were absent or reversed in those with more normal CSF synaptic protein. Postmortem analyses recapitulated CSF models. More normal brain tissue levels of complexin-I, VAMP, and SNARE moderated the adverse relationship between neuritic plaque and NFT counts (-0.10 <β < -0.08, p < 0.05). CONCLUSIONS: Pathogenic relationships of Aβ and tau may depend on synaptic state. Synaptic markers may help identify risk or resilience to AD proteinopathy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Casaletto KB, Zetterberg H, Blennow K, et al. Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study. Neurology. 2021. PMID: 33947778. doi:10.1212/WNL.0000000000012145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。